Chronic kidney disease and the aging population
Predicting hospital admissions by looking backwards
A ray of light in the dark
Assessment of arterial stiffness for clinical and epidemiological studies
Vascular endothelium
Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD)
Iron toxicity
Should we treat asymptomatic bacteriuria after renal transplantation?
The iron cycle in chronic kidney disease (CKD)
Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis
Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration
Paracrine effects of transplanted mesothelial cells isolated from temperature-sensitive SV40 large T-antigen gene transgenic rats during peritoneal repair
Intra-renal transfection of heat shock protein 90 alpha or beta (Hsp90α or Hsp90β) protects against ischemia/reperfusion injury
KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis
All anti-vascular endothelial growth factor drugs can induce ‘pre-eclampsia-like syndrome’
Definitions of progression in chronic kidney disease—predictors and relationship to renal replacement therapy in a population cohort with a 6 year follow-up
The association of a single-nucleotide polymorphism in CUBN and the risk of albuminuria and cardiovascular disease
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation incorporating both cystatin C and creatinine best predicts individual risk
Clinical implication of crescentic lesions in immunoglobulin A nephropathy
Prevalence and severity of oral disease in adults with chronic kidney disease
Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA
Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects
Collapsing glomerulopathy superimposed on diabetic nephropathy
Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa)
Effects of uric acid-lowering therapy on renal outcomes
High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients
Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data
Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis
Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis
Dynamics of hospitalizations in hemodialysis patients
Children of non-Western origin with end-stage renal disease in the Netherlands, Belgium and a part of Germany have impaired health-related quality of life compared with Western children
Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis
Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation
Stanley Shaldon (1931–2013)
Acidic stress–ER stress axis for blunted activation of NF-κB in mesothelial cells exposed to peritoneal dialysis fluid